Lysophosphatidic acid-induced arterial wall remodeling: Requirement of PPARγ but not LPA1 or LPA2 GPCR
Authors:
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 21 (12) , 1874-1884
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL79004)
- American Heart Association (0530106N)
This publication has 42 references indexed in Scilit:
- Unique Ligand Selectivity of the GPR92/LPA5 Lysophosphatidate Receptor Indicates Role in Human Platelet ActivationJournal of Biological Chemistry, 2009
- New Mechanism of Rosiglitazone to Reduce Neointimal HyperplasiaArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in miceJournal of Clinical Investigation, 2009
- The early- and late stages in phenotypic modulation of vascular smooth muscle cells: Differential roles for lysophosphatidic acidBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3Biochemical and Biophysical Research Communications, 2007
- Platelet Interaction with Bioactive Lipids Formed by Mild Oxidation of Low-Density LipoproteinPathophysiology of Haemostasis and Thrombosis, 2006
- PPARγ Gene Transfer Sustains Apoptosis, Inhibits Vascular Smooth Muscle Cell Proliferation, and Reduces Neointima Formation After Balloon Injury in RatsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Dyslipidemia Associated with Atherosclerotic Disease Systemically Alters Dendritic Cell MobilizationImmunity, 2004
- Increased Expression of Peroxisome Proliferator-Activated Receptor-α and -γ in Blood Vessels of Spontaneously Hypertensive RatsHypertension, 2001
- Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA speciesFEBS Letters, 2000